GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 69 filers reported holding GENERATION BIO CO in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $117,069 | +19.7% | 30,889 | +73.7% | 0.00% | – |
| Q2 2023 | $97,823 | +100.5% | 17,786 | +70.2% | 0.00% | – |
| Q1 2023 | $48,787 | -99.3% | 10,447 | -95.8% | 0.00% | -100.0% |
| Q2 2021 | $6,628,000 | +63.5% | 246,377 | +72.9% | 0.01% | +66.7% |
| Q1 2021 | $4,055,000 | +19.3% | 142,494 | +18.8% | 0.00% | 0.0% |
| Q4 2020 | $3,400,000 | -11.1% | 119,922 | -3.1% | 0.00% | 0.0% |
| Q3 2020 | $3,824,000 | +49.0% | 123,708 | +1.3% | 0.00% | +50.0% |
| Q2 2020 | $2,566,000 | – | 122,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |